EP Patent

EP0235090B1 — Composition useful in the treatment of estrogen deficiencies

Assigned to Warner Lambert Co LLC · Expires 1993-09-15 · 33y expired

What this patent protects

Medication and pharmaceutical composition containing at least one synthetic estrogenic compound and at least one progestogenic compound for the treatment of estrogen deficiency.

USPTO Abstract

Medication and pharmaceutical composition containing at least one synthetic estrogenic compound and at least one progestogenic compound for the treatment of estrogen deficiency.

Drugs covered by this patent

Patent Metadata

Patent number: EP0235090B1
Jurisdiction: EP
Classification: —
Expires: 1993-09-15
Drug substance claim: No
Drug product claim: No
Assignee: Warner Lambert Co LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.